Washington, D.C. – The Board of Pharmacy Specialties (BPS) has voted to issue a call for petition in both Cardiology and Infectious Diseases. As part of this deliberation, the BPS Board of Directors reviewed the role delineation studies conducted in these two pharmacy practice areas and found the results supportive of further consideration of Cardiology and Infectious Diseases as pharmacy specialties.
Current BPS Chairman John A. Pieper, Pharm.D., FCCP, President of the St. Louis College of Pharmacy, commented; “The call for petitions in both Cardiology and Infectious Diseases reinforces the commitment of BPS to explore new pharmacy specialties to recognize the ever increasing role of Board Certified Pharmacists in today’s health care system. BPS looks forward to receiving petitions in these two important areas of pharmacy practice.”
BPS Executive Director William Ellis notes; “The Board believes that this decision will not impact the current BPS certification framework discussion and that both the framework discussion and this call for petitions can take place concurrently. Additionally, the Board has not made any decision regarding the Added Qualifications program that currently exists in these two pharmacy practice areas. A decision on Added Qualifications would be premature until the petition review process is completed.”
The petitions will need to address, in detail, each of the criteria deemed necessary for a new specialty to be recognized by BPS. Those criteria include:
- Specialized Knowledge
- Specialized Functions
- Education and Training
- Transmission of Knowledge
Finally, BPS has made revisions to the petition process that reflects input BPS has received over the past three years. A revised petition process will be posted to the BPS website on May 27, 2015.